The FDA has repeatedly flagged AOD 9604 as a compound of concern. It was placed on the Category 2 list in 2023 bulk drug substances in compounding that may present significant AOD 9604 Bulk Supply buy from factory 99% Purity powder RFK Jr. may reverse a peptide ban he calls 'illegal.' Former FDA officials say he mischaracterized their work. The Lund Report Watson responsible for AOD 9604 use, says WADA boss Fahey Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York